BAYN.DE · Bayer AG

DAX · EURO STOXX 50 · XETRA

Risiko 8/10 · Litigation + Debt Distress · €47.03 ▼ 0.42%

Kennzahlen

• Price €47.03
• Market cap €46.2B
• P/E (ttm) n/a
• Div yield 0.23%
• 52-wk range €24.80 – €53.92

Wichtigste Risiken

• Roundup/glyphosate litigation (US mass torts) (Cash, ratings & solvency optionality) — EXTREME
• PCB litigation claims (Additional legal provisions) — HIGH
• Pharma patent cliff (Xarelto, Eylea biosimilar pressure) (Revenue base from 2026+) — HIGH
• High leverage constraining R&D investment (Pipeline competitiveness) — HIGH

Fazit

Monsanto acquisition has turned into a near-existential liability; resolution of US litigation is the single make-or-break variable for the equity.

Interaktive Analyse öffnen → Teilen

Recherche, keine Anlageberatung.